The Global Defibrillator Market is likely to expand considerably in the coming years due to the increasing incidence of out of hospital cardiac arrests. According to a report published by Fortune Business Insights, titled “Defibrillator: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 9,836.8 Mn in 2018. Fortune Business Insights states that the market will be valued at US$ 14,806.4 Mn by 2026, thereby exhibiting a CAGR of 5.3% during the forecast period.
FDA Approves Wearable Defibrillator for Children
The FDA approved ‘LifeVest’ defibrillator has been successful ever since it was announced in 2017. The LifeVest was launched as a wearable device, suitable for children at the risk of sudden cardiac arrest. The device consists of an electrode belt and a cloth that surrounds the chest of the patient using it. Additionally, the device also makes use of a monitor that is used for real time analysis. The efficacy of the device has lifted the otherwise moderately rising defibrillator market. The device provides a shock to the heart, whenever a failure is detected, allowing it to restore its heartbeat. LifeVest has a positive outcome on the global defibrillators market and is likely to enable growth of the market in the coming years.
Segmentation
By Type
- Implantable Cardioverter Defibrillator (ICD)
. Transvenous ICD
. Single Chamber ICD
. Dual Chamber ICD
. CRT-D (cardiac resynchronization therapy- defibrillator)
. Subcutaneous ICD
- External Defibrillator
. Automated External Defibrillator (AED)
. Manual and Semi-automatic External Defibrillator
. Wearable External Defibrillator
By End User
- Hospitals & Clinics
- Ambulatory, Schools and other Public Places
By Geography
- North America (USA and Canada)
- Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
- Rest of the World
Boston Scientific Proposes a Defibrillator with 70% More Pacing Options
Boston Scientific receives FDA approval for its newest range of defibrillators, designed to better patient care. The company received approvals for Dynagen Mini and Inogen Mini, along with Dynagen X4 and Inogen X4. The company claims that the X4 lines of defibrillators offer 70% more pacing options for gathering elevated threshold levels. The size of these devices are what differentiates them from its counterparts and it has created a rising uptake within end users. The company has submitted on its website that these devices are approximately 20% smaller than the existing devices, produced by its counterparts. The approvals for Boston Scientific’s latest devices is likely to enable the growth of the global market in the forthcoming years.
Key players leading the global market include
- Asahi Kasei Corporation,
- Philips Healthcare,
- Defibtech, LLC.,
- Cardiac Science,
- Stryker,
- CU Medical System Inc.,
- Medtronic Boston Scientific Corporation,
- Biotronik,
- LivaNova Plc
Get PDF Brochure of this Report@ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/defibrillators-market-100950
Some major points from Table of Content:
1. Introduction
1.1.Research Scope
1.2.Market Segmentation
1.3.Research Methodology
1.4.Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
4.Key Insights
4.1. Prevalence of Sudden Cardiac Arrests in Key Countries
4.2. Recent Industry Developments such as Mergers & Acquisitions
4.3. The Regulatory Scenario in Key Countries
4.4. New Products Launches by Key Players
4.5. Reimbursement Scenario for Key Countries
4.6. Key Industry Trends
5. Global Defibrillator Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Type
5.2.1.Implantable Cardioverter Defibrillator (ICD)
5.2.1.1 Transvenous ICD
5.2.1.1.1. Single Chamber ICD
5.2.1.1.2. Dual Chamber ICD
5.2.1.1.3. CRT-D (cardiac resynchronization therapy- defibrillator)
5.2.1.2. Subcutaneous ICD
5.2.2. External Defibrillator
5.2.2.1. Automated External Defibrillator (AED)
5.2.2.2. Manual and Semi-automatic External Defibrillator
5.2.2.3. Wearable External Defibrillator
5.3. Market Analysis, Insights and Forecast – By End User
5.3.1. Hospitals & Clinics
5.3.2. Schools and other Public Places
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia pacific
5.4.4. Rest of the World
6. North America Defibrillator Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis – By Type
6.2.1. Implantable Cardioverter Defibrillator (ICD)
6.2.1.1. Transvenous ICD
6.2.1.1.1. Single Chamber ICD
6.2.1.1.2. Dual Chamber ICD
6.2.1.1.3. CRT-D (cardiac resynchronization therapy- defibrillator)
6.2.1.2. Subcutaneous ICD
6.2.2. External Defibrillator
6.2.2.1. Automated External Defibrillator (AED)
6.2.2.2. Manual and Semi-automatic External Defibrillator
6.2.2.3. Wearable External Defibrillator
6.3. Market Analysis – By End User
6.3.1. Hospitals & Clinics
6.3.2. Schools and other Public Places
6.4. Market Analysis – By Country
6.4.1. U.S.
6.4.2. Canada
7. Europe Defibrillator Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis – By Type
7.2.1. Implantable Cardioverter Defibrillator (ICD)
7.2.1.1. Transvenous ICD
7.2.1.1.1. Single Chamber ICD
7.2.1.1.2. Dual Chamber ICD
7.2.1.1.3. CRT-D (cardiac resynchronization therapy- defibrillator)
7.2.1.2. Subcutaneous ICD
7.2.2. External Defibrillator
7.2.2.1. Automated External Defibrillator (AED)
7.2.2.2. Manual and Semi-automatic External Defibrillator
7.2.2.3. Wearable External Defibrillator
7.3. Market Analysis – By End User
7.3.1. Hospitals & Clinics
7.3.2. Schools and other Public Places
7.4. Market Analysis – By Country/ Sub-region
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Spain
7.4.5. Italy
7.4.6. Scandinavia
7.4.7. Rest of Europe
Order Full Report@ https://www.fortunebusinessinsights.com/checkout-page/100950
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
